中华肿瘤杂志
中華腫瘤雜誌
중화종류잡지
CHINESE JOURNAL OF ONCOLOGY
2014年
3期
228-231
,共4页
黄海%徐绍年%杜振广%李福生%王亮
黃海%徐紹年%杜振廣%李福生%王亮
황해%서소년%두진엄%리복생%왕량
骨肿瘤%肿瘤转移,胸椎,腰椎%经皮椎体成形术%组织间125I放射粒子植入术
骨腫瘤%腫瘤轉移,胸椎,腰椎%經皮椎體成形術%組織間125I放射粒子植入術
골종류%종류전이,흉추,요추%경피추체성형술%조직간125I방사입자식입술
Bone neoplasms%Neoplasm metastasis,thoracic vertebrae,lumbar vertebrae%Percutaneous vertebroplasty%Interstitial implantation of 125I seeds
目的 探讨组织间125I放射粒子植入联合经皮椎体成形术治疗胸腰椎转移瘤的价值.方法 对18例胸腰椎转移瘤患者的22节病变椎体进行放射粒子植入术前计划,在CT引导局麻下行25I放射粒子植入术,术后复查CT,进行质量验证.在数字减影血管造影机器引导局麻下经皮经椎弓根穿刺,将骨水泥注入病变椎体.结果 18例胸腰椎转移瘤患者均成功进行了组织间125I放射粒子植入联合经皮椎体成形术,每节椎体植入放射粒子16 ~ 34颗,平均26颗;每节椎体骨水泥的注入量约2~6 ml,平均3.5 ml.术前和术后2个月患者的数字疼痛分级法疼痛评分分别为(7.12±1.48)分和(2.26±1.07)分,差异有统计学意义(P<0.05).15例患者的神经功能较术前改善,3例患者的神经功能较术前无明显变化.结论 组织间125I放射粒子植入联合经皮椎体成形术治疗胸腰椎转移瘤具有创伤小、并发症少、无需外放疗等特点,能有效缓解患者疼痛,限制肿瘤生长,提高患者的生存质量,是一种有前景的治疗胸腰椎转移瘤的微创方法.
目的 探討組織間125I放射粒子植入聯閤經皮椎體成形術治療胸腰椎轉移瘤的價值.方法 對18例胸腰椎轉移瘤患者的22節病變椎體進行放射粒子植入術前計劃,在CT引導跼痳下行25I放射粒子植入術,術後複查CT,進行質量驗證.在數字減影血管造影機器引導跼痳下經皮經椎弓根穿刺,將骨水泥註入病變椎體.結果 18例胸腰椎轉移瘤患者均成功進行瞭組織間125I放射粒子植入聯閤經皮椎體成形術,每節椎體植入放射粒子16 ~ 34顆,平均26顆;每節椎體骨水泥的註入量約2~6 ml,平均3.5 ml.術前和術後2箇月患者的數字疼痛分級法疼痛評分分彆為(7.12±1.48)分和(2.26±1.07)分,差異有統計學意義(P<0.05).15例患者的神經功能較術前改善,3例患者的神經功能較術前無明顯變化.結論 組織間125I放射粒子植入聯閤經皮椎體成形術治療胸腰椎轉移瘤具有創傷小、併髮癥少、無需外放療等特點,能有效緩解患者疼痛,限製腫瘤生長,提高患者的生存質量,是一種有前景的治療胸腰椎轉移瘤的微創方法.
목적 탐토조직간125I방사입자식입연합경피추체성형술치료흉요추전이류적개치.방법 대18례흉요추전이류환자적22절병변추체진행방사입자식입술전계화,재CT인도국마하행25I방사입자식입술,술후복사CT,진행질량험증.재수자감영혈관조영궤기인도국마하경피경추궁근천자,장골수니주입병변추체.결과 18례흉요추전이류환자균성공진행료조직간125I방사입자식입연합경피추체성형술,매절추체식입방사입자16 ~ 34과,평균26과;매절추체골수니적주입량약2~6 ml,평균3.5 ml.술전화술후2개월환자적수자동통분급법동통평분분별위(7.12±1.48)분화(2.26±1.07)분,차이유통계학의의(P<0.05).15례환자적신경공능교술전개선,3례환자적신경공능교술전무명현변화.결론 조직간125I방사입자식입연합경피추체성형술치료흉요추전이류구유창상소、병발증소、무수외방료등특점,능유효완해환자동통,한제종류생장,제고환자적생존질량,시일충유전경적치료흉요추전이류적미창방법.
Objective To explore the value of percutaneous vertebroplasty combined with interstitial implantation of 125I seeds in the treatment of metastatic thoracolumbar tumors.Methods Based on the CT images before 125I seed implantation,a computer-based treatment planning system (TPS) was used to determine the optimal seed distribution.Under CT guidance and local anaesthesia,125 I seeds were implanted into 22 osseous metastatic lesions in 18 patients.Based on the CT images after the implantation,quality check was carried out with TPS.DSA (digital subtraction angiography)-guided vertebroplasty was performed under local anaesthesia,and bone cement was injected into the vertebrae through pedicle of vertebral arch.Results All the 18 patients received percutaneous vertebroplasty combined with interstitial implantation of 125I seeds.Every vertebra was injected with 2-6 ml bone cement,average 3.5 ml,and was injected with 125I seeds 16-34 pills,average 26 pills.At 2-months follow-up,their numerical rating scale (NRS) pain scores were 7.12 ± 1.48 before and 2.26 ± 1.07 after treatment,with a significant difference (P < 0.05).Conclusions Pereutaneous vertebroplasty combined with interstitial implantation of 125I seeds is a minimally invasive procedure with small wound and minor complications,and no need of external radiation therapy.It is effective in the alleviation of pain in metastatic thoracolumbar tumor patients,restrains the tumor growth,and improves the quality of life.It is a promising minimally invasive method in the treatment of metastatic thoracolumbar tumors.